Featuring exclusive comments from Dr. George Bakris
Studies are rarely stopped early; when it happens, we should take notice of the results.
Comparison of the Effects of GLP1-RA and SGLT2i
GLP1-RA and SGLT2i reduce atherosclerotic major cardiovascular events (MACE) to a similar degree in patients with established ASCVD.
Read More »Is Metformin Therapy Safe For Use In Stage 3 Chronic Kidney Disease?
Metformin may help lower the risk of cardiovascular events and death in patients with moderate to severe renal function.
Read More »Whose Responsibility is this ARB Issue?
This may not be an actual “physical” disaster averted yet because we don’t know the long-term effects on the people who have taken the ARBs and possibly other medications that were tainted with carcinogens or other “poisons.” When we (health care providers) were first notified of this issue, my first …
Read More »Insulin Dose, Cardiovascular Disease Risk and Outcomes
Intensive diabetes therapy can be associated with excess weight gain, central obesity, and dyslipidemia with increased heart disease risk.
Read More »Fasting Glucose Estimates Absolute Risk for CVD
Monitoring glucose in midlife may help prevent future cardiovascular disease, according to a study published in Diabetes Care.
Read More »New Oral GLP-1 Application Submitted to FDA
Novo Nordisk requests approval for new type 2 treatment with heart benefits.
Read More »Using Glycemic Variability To Predict Major Cardiac Events In Patients with Type 2 Diabetes
Too many highs and lows in glucose levels could be another reason that causes cardiovascular complications.
Read More »Does Intensive Blood Pressure Control Prevent Strokes?
Maintaining a blood pressure below 130/80 mm Hg can eventually reduce the risk of having a repeat stroke, according to a recent study.
Read More »Metformin Safety In Patients With Chronic Kidney Disease And Its Benefits
In patients with stage 3 kidney disease, metformin use may be safe and may reduce the risk of mortality and cardiovascular events.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.